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Letter to editor

Vaccine hesitancy and considerations for vaccination
campaigns against COVID-19
Shyh Poh, Teo*
Department of Internal Medicine, Raja Isteri Pengiran Anak Saleha (RIPAS) Hospital, Bandar Seri
Begawan, Brunei Darussalam
Many countries are eagerly waiting for the
availability of coronavirus disease 2019 (COVID-19)
vaccines, with the hope that a large-scale immunization
program would provide a reprieve from the current
pandemic. Vaccine effectiveness requires a high
population uptake and the development of herd
immunity, while vaccine hesitancy threatens the
likelihood of successfully containing the infection
through vaccination. COVID-19 vaccine hesitancy
has been reported even in areas severely affected
by the pandemic, ranging from as low as 2.0% in
China up to 44.0% in Turkey. (1) Selected studies of
COVID-19 vaccine hesitancy are discussed to
emphasize important considerations for COVID-19
vaccination campaigns. These studies were identified
through Google Scholar for the search terms
‘COVID-19’ and ‘vaccine hesitancy’ performed on
15th January 2021.
In the United States, an online survey found
69.0% of the participants were willing to receive a
COVID-19 vaccine. Willingness to get vaccinated
was associated with perceived likelihood of contracting
a COVID-19 infection, perceived severity of infection
and perceived effectiveness of the vaccine. (2) This is
consistent with the health belief model for predicting
vaccine intention, where predictors of vaccine uptake
include high-perceived benefits and lower perceived
barriers to receiving the vaccine. Interventions to
improve vaccine uptake should target these constructs
to increase vaccine demand. (3)
An Australian online survey found 85.8% of their
respondents were willing to receive a COVID-19
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vaccine. Those less likely to be vaccinated believed
that the threat of COVID-19 was exaggerated. (4)
This raises the possibility that vaccine uptake may
wane when the perceived threat from the pandemic
diminishes, particularly during times of reduced
restrictions. Inadequate health literacy and lower
education levels were also associated with vaccine
hesitancy, indicating more effort is required to target
these groups for vaccine education. (4)
An Italian study found that although older
people were more susceptible to COVID-19 related
complications and were a priority for immunization,
they did not express more willingness to get vaccinated
compared to younger, healthier people. (5) In addition
to older people, COVID-19 also disproportionately
affects certain vulnerable groups, including migrants,
minority groups, those with lower socioeconomic
status and living in densely populated areas. These
groups also have a higher rate of comorbid chronic
conditions, high risk of COVID-19 infections, severe
disease consequences, poor access to healthcare and
likely poor outcomes. Therefore, engagement and
collaboration specifically targeting these groups should
be emphasized to improve vaccine education and
acceptance.(6)
Another study identified a one in ten rate of
vaccine hesitancy among university students in Italy.
While healthcare curricula should result in higher
health literacy in healthcare students, there were no
differences in vaccine hesitancy when healthcare and
non-healthcare student responses were compared. (7)
This should be a cause for concern, as vaccination of
healthcare workers is crucial, due to close contact
with patients who are at high-risk of complications
from COVID-19 infections. Thus, health promotion
activities should also be carried out at educational
institutions to improve vaccine uptake.
A French study found a high rate of vaccine
hesitancy, where 26.0% of the respondents were
unwilling to receive a COVID-19 vaccine. This was
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despite a recent national outbreak, with frequent media
coverage of high death tolls and full intensive care
wards. (8) There was an association between the
political views of respondents and vaccine acceptance,
suggesting that political interests and opinions of public
authorities may play a part in vaccine hesitancy.
Political figures and governments should be aware of
their influence on vaccine uptake, contribute to
vaccine-related discussions in a balanced manner;
build public trust in the information given and the steps
taken by authorities to manage the pandemic. (9)
A Spanish study found that the public were averse
to ambiguity, such that communicating scientific
uncertainty reduced vaccine interest, affected their
perception of vaccine effectiveness and reduced trust
in health officials. Participants with higher literacy
levels had greater expectations of certainty in health
information, with an aversion towards uncertainty.
While further work is required to improve public
acceptance of scientific uncertainty, it is useful to
recognize that the unknown may diminish the
effectiveness of COVID-19 vaccine-related public
health communications. (10)
Finally, a study from Israel showed a difference
between occupations for vaccine hesitancy, with the
highest anti-vaccination attitudes among nurses,
followed by general public. Doctors reported the most
willingness to get vaccinated. (11) To improve the
uptake, Israel has given several incentives for people
to get vaccinated, which can be accessible through
a ‘green pass’. (12) This provides exemptions from
quarantine, with holders having less restrictions in
movement within the country. It is hoped that this
approach will further increase vaccine uptake within
the country.
In summary, vaccine hesitancy should be
evaluated in each locality prior to introduction of
COVID-19 vaccines. Vaccine education should target
those at risk of vaccine hesitancy and those at risk
of poor outcomes from COVID-19 infections.
Universities and higher education institutions should
also be prioritized for improving vaccine awareness.
Political figures have a role in building public trust and
influencing vaccine hesitancy. Vaccine information
should also avoid ambiguity as much as possible,
focusing on what is known and recommendations for
the public.
This letter covers general points for consideration
for vaccination campaigns to overcome vaccine
hesitancy. It is not possible to provide specific
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recommendations for each locality. As COVID-19
vaccines are being rolled-out internationally, there
may be new changes that affect COVID-19 vaccine
hesitancy, such as new emerging efficacy data or
adverse events following vaccination.
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